摘要
目的 :应用尿毒康治疗慢性肾衰 (CRF)并以肾安作对照观察临床疗效 .方法 :确定有慢性肾衰的患者 ,随机分为治疗组和对照组 .治疗组口服尿毒康 2 0mL ,3次·d-1;对照组肾安注射液 2 5 0mL ,1次·d-1.所有病例均常规服用潘生丁、碳酸氢钠、碳酸钙 .结果 :尿毒康有改善临床症状 ,使血肌酐(Scr)、尿素 (Urea)降低 ,血红蛋白 (Hb)和二氧化碳结合力(CO2 CP)升高的作用 ,且明显优于肾安组 .结论 :尿毒康可增强患者免疫功能 ,抑制机体代谢 ,从而保护残余肾单位 。
AIM: To evaluate the therapeutic effects of Niaodukang Jianji in treating chronic renal failure (CRF) and compare them with those of Shenan. METHODS: Patients with CRF were randomly divided into the treatment group and the control group. In the treatment group, patients orally took 20 ml Niaodukang 3 times a day while in the control group, patients were given an injection of 250 ml Shenan once a day. Patients in both groups routinely took dipyridamole, sodium bicarbonate and calcium carbonate. RESULTS: Niaodukang could relieve clinical symptoms, reduce Scr and Urea, increase Hb and CO2CP. The effects were obviously better than those of Shenan. CONCLUSION: Niaodukang can improve the patients immune function, inhibit metabolism and protect residual nephrons, thus effectively delaying CRF process.
出处
《第四军医大学学报》
北大核心
2003年第5期469-471,共3页
Journal of the Fourth Military Medical University
